CClinicalTrials.gg
CompletedNCT06815510Updated Sep 25, 2026

Prevalence of Post Anesthesia Care Unit Complications and Associated Factors

An observational study in Postoperative Care, Complications of Surgical Procedures or Medical Care and Inpatients, sponsored by Ángel Becerra-Bolaños, MD PhD. Completed at 4 sites in 2 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-25.

Sponsored by Ángel Becerra-Bolaños, MD PhD · Observational

Updated Sep 25, 2026Now CompletedPrimary completion moved+4 moreGo to Updates ↓
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
1,778
Ages
18 Years and older
Sex
All
01

Study summary

The post-anesthesia care unit (PACU) is a crucial component of the surgical process, providing patients with vital support and monitoring as they recover from anesthesia. Despite advancements in perioperative anesthesia, PACU complications are still common. PACU organization and setup in low-income country like Ethiopia is poor. Previous research's done in some neighbor African countries presumed to have comparable to sociodemographic and economical profile shows varied degree of incidence and prevalence of PACU complication and associated factors. The main objective of this study is to determine the prevalence of PACU complications and its associated factors.

An institutional based prospective cohort study will be conducted in the PACUs of the three selected tertiary care hospitals in Ethiopia from Februery 15, 2025 to June 30, 2025. These data will be compared with those obtained in a tertiary hospital in Spain.

Read the detailed description

Studying the prevalence and associated factors of PACU complications will be of great academic importance, serving as a valuable reference and resource for further research. It will also help identify risk factors attributable to PACU complications, providing critical insights for hospital administrators and policymakers in making informed decisions about resource allocation and system design to minimize these complications. Understanding the prevalence and potential risk factors of PACU complications is essential for optimizing patient care and improving outcomes. Identified risk factors for postoperative complications in the PACU include female sex, longer duration of anesthesia, and the occurrence of intraoperative complications. This study aims to explore the prevalence of complications in the PACU and identify potential contributing factors, providing valuable insights for healthcare providers and policymakers seeking to improve PACU care. the potential significance and implications of the study findings, includes; Improving the understanding of PACU complications and the associated risk factors, informing the development of targeted prevention and management strategies, enhancing patient safety and quality of care in the perioperative setting and providing a basis for future research and evidence-based clinical guidelines. The study will involve surgical patients admitted to the Post-Anesthesia Care Units (PACUs) of four hospitals: Hiwot Fana Comprehensive Specialized Hospital, Ayder Comprehensive Specialized Hospital, Jimma University Medical Center (Ethiopia) and Hospital Universitario de Gran Canaria Doctor Negrín (Spain). The research will take place from February 15, 2025, to June 30, 2025. Multicenter, prospective, observational cohort study will be conducted reviewing patients admitted to the PACU. Analyzing complications in all patients admitted to the PACUs at the four selected hospitals following surgery under general, regional, or monitored anesthesia will be included in the study.

02

Conditions studied

  • Postoperative Care
  • Complications of Surgical Procedures or Medical Care
  • Inpatients
  • Ethiopia
  • Multicenter Prospective Study

Keywords

  • postoperative complications
  • postanesthesia care unit
03

In context

Postoperative Complications

1,233 studies on the registry are indexed under Postoperative Complications; 292 are open to participants now.

This study's enrollment of 1,778 is above the median of 254 across 519 observational studies indexed under Postoperative Complications.

Browse Postoperative Complications studies →

Lead sponsor

Ángel Becerra-Bolaños, MD PhD is the lead sponsor of 2 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All patients admitted to the Post-Anesthesia Care Units (PACUs) following surgery under general, regional, or monitored anesthesia who have signed the informed consent preoperatively will be included in the study.

Inclusion criteria

  • All patients admitted to the Post-Anesthesia Care Units (PACUs) following surgery under general, regional, or monitored anesthesia

Exclusion criteria

Exclusion Criteria:

  • Patients who are taken directly to the ICU, ward, discharged, or transferred immediately after surgery.
  • Patients who do not provide informed consent for enrollment in the study.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
1,778 participants (actual)
Patient registry
No

Groups and cohorts

  • Patients admitted to the postanesthesia care unit

    Adult patients admitted to the postanesthesia care unit following surgery under general, regional, or monitored anesthesia

    Diagnostic Test: Questionnaire and Physical Exam

Interventions

  • Diagnostic testQuestionnaire and Physical Exam

    Patients will be followed up to find out any of these complications: pulmonary, hemodynamic complications, temperature disturbances, or pain

    Also known as: Postoperative complications in the PACU

06

What researchers measure

Primary outcomes

  1. Rate of patients with postoperative complications in the postanesthesia care unit

    Patients will be followed up during their stay in the PACU looking for the appearance of respiratory and hemodynamic complications, temperature disturbances or pain

    Time frame: 8 postoperative hours

07

Study locations

4 sites
  • Haramaya University
    Harar, Ethiopia
  • Jimma University
    Jimma, Ethiopia
  • Mekelle University
    Mek'ele, Ethiopia
  • Hospital Universitario de Gran Canaria Doctor Negrín
    Las Palmas de Gran Canaria, Spain
08

References and documents

Individual participant data

Plan to share: Undecided — IPD used in the results publication will be shared.

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Sep 25, 2026
Sites
1 site added, 1 site removed
Show site
  • Mekelle University · Mek'ele, Ethiopia
Show 1 removed
  • Mekelle University · Mekelle, Ethiopia
Sep 25, 2026
Primary completion
Jun 30, 2025→Nov 30, 2025 (actual)
Sep 25, 2026
Study completion
Jul 1, 2025→Nov 30, 2025 (actual)
Sep 25, 2026
Enrollment
1532 (estimated)→1778 (actual)
Sep 25, 2026
Show all 1 update
  1. Sep 25, 2026
    Recruiting→Completed
    1 site added, 1 site removed
    Show site
    • Mekelle University · Mek'ele, Ethiopia
    Show 1 removed
    • Mekelle University · Mekelle, Ethiopia
    Primary completion Jun 30, 2025→Nov 30, 2025 (now actual)
    Study completion Jul 1, 2025→Nov 30, 2025 (now actual)
    Enrollment 1532 (estimated)→1778 (actual)
    + 5 other changes: identifiers, responsible party, oversight details, contact details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06815510
Lead sponsor
Ángel Becerra-Bolaños, MD PhD
Collaborators
Mekelle University, Jimma University, Haramaya Unversity
Responsible party
Ángel Becerra-Bolaños, MD PhD (Principal Investigator, Hospital Universitario de Gran Canaria Doctor Negrín) — Sponsor-investigator
First posted
Feb 7, 2025
Start date
Feb 24, 2025
Primary completion
Nov 30, 2025
Completion
Nov 30, 2025
Last update
Sep 25, 2026

Study contacts

Ataklti Adhanom, MD
principal investigator · Mekelle University
Sirak Worku, MD
principal investigator · Haramaya University
Badhaasaa Beyene, MD
principal investigator · Haramaya University
Ruth Desta, MD
principal investigator · Haramaya University
Edosa Kejela, MD
principal investigator · Jimma University
Ángel Becerra-Bolaños, MD PhD
principal investigator · Hospital Universitario de Gran Canaria Doctor Negrín
Fekrey Berhe Gebru, MD
principal investigator · Mekelle University
Frtuna Zeray, MD
principal investigator · Mekelle University
Aemero Awoke, MD
principal investigator · Jimma University
Teklay Tesfay, MD
principal investigator · Mekelle University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion